Novavax becomes Australia’s 5th approved COVID-19 vaccine Novavax’s COVID-19 vaccine has become the fifth coronavirus vaccine approved for use in Australia

CANBERRA, Australia — Novavax’s COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia.

The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population of 26 million. Pfizer, AstraZeneca and Moderna vaccines are already in use in Australia. Johnson and Johnson’s Janssen vaccine is also approved but the government has not bought any.

Read More